Among the molecules involved in FAS signaling, the death receptor FAS, i.e., its deficiency, has been shown to be the most important in the progression of bladder tumors [16], which is in accordance with our finding that high FAS predicts superior outcome and longer overall survival in UBC. Here, FAS is linked to urinary bladder neoplasm.